Earlier R&D Programs, Maturing Candidates Emerge From Bristol’s Pipeline

Mid-Stage Milvexian Cleared First Proof-Of-Concept Hurdle

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.